SCHEMBL16624927

SCHEMBL16624927

COc1ccc(C(=O)CC(CC(=O)OC/C=C/c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.60
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 7/20 0.46
MAPT P10636 4/20 0.46
HSPD1 P10809 1/20 0.46
TNFRSF1A P19438 1/20 0.46
MAOB P27338 1/20 0.46
HSPE1 P61604 1/20 0.46
CYP1B1 Q16678 1/20 0.46
ATM Q13315 1/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
HTT P42858 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16624917 0.90 L3MBTL1 (0.49) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL16624897 0.89 L3MBTL1 (0.44) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL16624892 0.85 L3MBTL1 (0.71) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL19071457 0.82 CACNA1B (0.45) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL16624924 0.82 ALDH1A1 (0.45) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL16624900 0.81 L3MBTL1 (0.76) L3MBTL1KMT2AALDH1A1MAPTATM
SCHEMBL19071159 0.80 L3MBTL1 (0.37) L3MBTL1ALDH1A1MAPTATMTDP1
SCHEMBL16624918 0.79 L3MBTL1 (0.64) L3MBTL1ALDH1A1MAPTATMNPC1
SCHEMBL19071295 0.78 L3MBTL1 (0.81) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL16624890 0.78 L3MBTL1 (0.81) L3MBTL1ALDH1A1MAPTATMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2864284-B1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO KGAA (DE) 2017-07-05 EP disclosed
US-9458081-B2 Photolabile pro-fragrances HENKEL AG & CO. KGAA (DE) 2016-10-04 US disclosed
US-9458081-B2 Photolabile pro-fragrances HENKEL AG & CO. KGAA (DE) 2016-10-04 US disclosed
US-20150099809-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2015-04-09 US disclosed
US-20150099809-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099809-A1 PHOTOLABILE PRO-FRAGRANCES TRPA1, PSAP, CRY1 L3MBTL1 1799/4885MEN1 556/4885KMT2A 2118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.